Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes
- 25 September 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 75 (1), 67-75
- https://doi.org/10.1007/s00228-018-2558-6
Abstract
This study aimed to investigate the effects of clotrimazole on the pharmacokinetics of tacrolimus in Japanese patients with heart transplants with different CYP3A5 genotypes.Keywords
This publication has 37 references indexed in Scilit:
- Important Drug Interactions in Hematopoietic Stem Cell Transplantation: What Every Physician Should KnowTransplantation and Cellular Therapy, 2012
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part IClinical Pharmacokinetics, 2010
- Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolamBritish Journal of Clinical Pharmacology, 2010
- Oral mucosal fungal infectionsPeriodontology 2000, 2008
- Therapeutic Monitoring of Calcineurin Inhibitors for the NephrologistClinical Journal of the American Society of Nephrology, 2007
- EFFECT OFCYP3A5POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRODrug Metabolism and Disposition, 2006
- Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantationNephrology Dialysis Transplantation, 2001
- Tacrolimus whole blood concentrations correlate closely to side‐effects in renal transplant recipientsBritish Journal of Clinical Pharmacology, 1999
- Estimation of Mean Residence Time from DataObtained when Multiple-Dosing Steady StateHas Been ReachedJournal of Pharmaceutical Sciences, 1984